Lithium Starting Dose and Side Effects
Starting Dose
The recommended initial lithium carbonate dose is 450-900 mg per day (12-24 mmol), adjusted based on age and body weight, with lower starting doses of 300-450 mg/day appropriate for elderly patients or those at higher risk of toxicity. 1
Age-Based Dosing Strategy:
- Patients <40 years: Start 450-900 mg/day, targeting maintenance of 925-1300 mg/day 1
- Patients 40-60 years: Start lower end of range, targeting maintenance of 740-925 mg/day 1
- Patients >60 years: Start 300-450 mg/day, targeting maintenance of 550-740 mg/day 1
Dosing Schedule:
- Once-daily dosing (single evening dose) is preferred for improved tolerability and compliance, particularly reducing urinary frequency compared to divided dosing 2
- Sustained-release formulations allow twice-daily dosing and reduce peak plasma concentrations by 30-50% without changing overall exposure 1
- Target serum levels: 0.6-0.8 mmol/L (some sources suggest 0.8-1.2 mmol/L for acute treatment) 1, 3
Critical Monitoring Requirements:
- Serum lithium levels must be checked twice weekly during initiation until stable 4, 5
- Draw levels 12 hours post-dose for standard formulations, or 24 hours post-dose for once-daily regimens 1
- Baseline labs required: Complete blood count, thyroid function, urinalysis, BUN, creatinine, serum calcium, and electrolytes 5
- Ongoing monitoring every 3-6 months: GFR, electrolytes, lithium levels, and thyroid function once stable 4, 5
Common Side Effects
Renal Effects (Most Clinically Significant):
- Polyuria and polydipsia are common, with twice-daily dosing causing significantly higher urinary frequency than once-daily 2
- Nephrotoxicity may occur even at therapeutic levels with prolonged use, causing renal tubular dysfunction 4
- Renal impairment is a contraindication to lithium use 1
Neurological Effects:
- Tremor, cognitive slowing, and impaired memory occur commonly, particularly affecting vigilance, alertness, learning, and short-term memory with long-term use 1
- Dysarthria may worsen in patients with pre-existing speech disorders 6, 5
- Elderly patients are particularly prone to neurotoxicity at higher doses 4
- Cerebellar dysfunction can occur at toxic levels >2 mmol/L 7
Endocrine Effects:
- Thyroid dysfunction requires regular monitoring 5
Cardiovascular Effects:
- Bradycardia, T-wave changes, and AV block have been described 8
- QT prolongation effects are divergent in reports 8
Hematologic Effects:
- Granulocytosis and lymphopenia are expected effects 7
Gastrointestinal Effects:
- Nausea and GI upset, though sustained-release or once-daily formulations significantly reduce GI side effects 1, 2
Critical Safety Warnings
Narrow Therapeutic Index:
- Toxicity occurs at doses close to therapeutic levels (>1.5 mmol/L causes mild reversible toxicity; >2 mmol/L causes neurological symptoms; prolonged levels >2 mmol/L cause permanent brain damage) 4, 7
Drug Interactions:
- Avoid NSAIDs—they decrease lithium clearance and increase toxicity risk 4
- Caution with antiarrhythmics and other medications affecting renal function 8
Special Populations:
- Pregnancy: May cause fetal harm based on animal and limited human studies 4
- Breastfeeding: Lithium passes freely into breast milk 1
- Renal impairment: Contraindication due to decreased clearance 1
- Elderly: Require lower doses and more frequent monitoring due to neurotoxicity risk 4, 1